economic recession will continue,
more n more money will withdraw from stock market,

only health care sector will be in top profit this pandemic time.

yesterday covid cases 382k ,
today new cases 397k cases,
if this continue spreading,
next week will reach 400k.

one sabah election our virus cases gone up like crazy. imagine US election in november + winter.

Strong demand offsets labor exploitation storm, and the outlook for glove stocks continues to rise
Report: Lin Zhibin


(Kuala Lumpur, 15th) Chinese glove manufacturers have been accused of forced labor again, but analysts believe that global glove demand remains strong and the outlook for glove stocks remains intact.




Today, the U.S. Department of Labor included the gloves produced in our country on the list of suspected child labor or forced labor, which caused our country's glove stocks to be sold down this morning.


Among them, top gloves (TOPGLOV, 7113, main board health stocks) once fell 2.74% in early trading; He Tejia (HARTA, 5168, main board health stocks) also fell the most by 2.75%, and the remaining glove stocks fell one after another.


However, Mercury Securities analyst Hu Wenyao believes that this is just an arbitrage behavior by investors. As long as the 2019 COVID-19 epidemic continues, global glove demand will continue to rise.




"(Being on the US list of suspected forced labor) will have a short-term impact, but the key is the global demand for gloves."


US election tricks


He also believes that this may just be a political ploy before the US election.




Xie Fulong, research director of Industrial Investment Bank, also pointed out that no matter how the United States views gloves produced in my country, during the epidemic, the global demand for gloves and other personal protective equipment is very large, and my country's glove manufacturers are not worried that there will be no market.


"my country produces 63% of the world's gloves, and manufacturers are opening up full capacity to supply the world. Unless the United States can be self-sufficient, there will still be a market for my country's gloves."

haha,
glove in shortage world wide, order cancelled?
nice

market sentiment not good, because of increase covid cases and politics issue,
money will be withdraw from other counter sector, and will be pour into healthcare sector, especially glove.

yeap,
normal pullback,
it is good timing for entry.

tomorrow will red when open, and green in the afternoon.

relax,
it is normal,
pullback after green few days.
stock change hands, create strongger support

relax,
look at the volume,
now stock changing hand,
preparing to fly,
park some,
while it below 0.80

TP rm1 at least,
it is glove business.
will sustained as long as covid around

good management will know what to do during this pandemic time,
and grab the opportunity to adapt with current situation.

now covid out of control, worldwide,
other sector already have bad time during mco,
now, having hard time recovering,
healthcare sector will in top profit this time on,
lead by glove bussiness.

OTHERS MAH SING GROUP BERHAD ("MAH SING" OR "COMPANY") PROPOSED DIVERSIFICATION OF THE PRINCIPAL ACTIVITIES OF MAH SING TO INCLUDE MANUFACTURING AND TRADING OF GLOVES AND RELATED HEALTHCARE PRODUCTS ("GLOVES BUSINESS") ("PROPOSED DIVERSIFICATION")


OTHERS MAH SING GROUP BERHAD ("MAH SING" OR "COMPANY") PROPOSED DIVERSIFICATION OF THE PRINCIPAL ACTIVITIES OF MAH SING TO INCLUDE MANUFACTURING AND TRADING OF GLOVES AND RELATED HEALTHCARE PRODUCTS ("GLOVES BUSINESS") ("PROPOSED DIVERSIFICATION")
MAH SING GROUP BERHAD

Type Announcement
Subject OTHERS
Description MAH SING GROUP BERHAD ("MAH SING" OR "COMPANY")
PROPOSED DIVERSIFICATION OF THE PRINCIPAL ACTIVITIES OF MAH SING TO INCLUDE MANUFACTURING AND TRADING OF GLOVES AND RELATED HEALTHCARE PRODUCTS ("GLOVES BUSINESS") ("PROPOSED DIVERSIFICATION")
On behalf of the Board of Directors of Mah Sing (“Board”), Hong Leong
Investment Bank Berhad (“HLIB”) wishes to announce that the Company is
proposing to undertake the proposed diversification of the principal
activities of Mah Sing to include manufacturing and trading of gloves and
related healthcare products.

at this rate,
soon 400k+ average daily case,
seems covid spreading out of control.
today 372k new cases worldwide.

it is good and healthy for the price,
steady up, more stable,
as we know it is uptrend, as long as covid19 with us.

profit taking is normal,
it is better, as the stock change hand,
create better price support.

relax,
covid rvaging,
all glove uptrend

i sell to u rm11 mtr27

slow and steady,
once break block at rm4,
no more rm3 boat

will follow top 4,
they green,
all glov green.

simple

last boat,
before rm4

since it already past rm9, doesnt mattet how many heavy selling block there are.

because it will be least rm10 next month

covid ravaging,
glove uptrend.

nothing can stop it.

as covid ravaging mys,
othet sector will having bad time to recover, and continue bussiness,
investor will slowly withdraw their capital,
and invest in healthcare,
as it is the only sector that will in top profit during pandemic.

glove will lead the healthcare bussiness.

it is time to buy on dip, when people panic sell because of politics.

PARIS: Covid-19 patients may experience more severe symptoms the second time they are infected, according to research released on Tuesday confirming it is possible to catch the potentially deadly disease more than once.

A study published in The Lancet Infectious Diseases journal charts the first confirmed case of Covid-19 reinfection in the United States – the country worst hit by the pandemic – and indicates that exposure to the virus may not guarantee future immunity.


The patient, a 25-year-old Nevada man, was infected with two distinct variants of SARS-CoV-2, the virus that causes Covid-19, within a 48-day time frame.

The second infection was more severe than the first, resulting in the patient being hospitalised with oxygen support.

The paper noted four other cases of reinfection confirmed globally, with one patient each in Belgium, the Netherlands, Hong Kong and Ecuador.

Experts said the prospect of reinfection could have a profound impact on how the world battles through the pandemic.

In particular, it could influence the hunt for a vaccine – the current Holy Grail of pharmaceutical research.

"The possibility of reinfections could have significant implications for our understanding of Covid-19 immunity, especially in the absence of an effective vaccine," said Mark Pandori, for the Nevada State Public Health Laboratory and lead study author.

"We need more research to understand how long immunity may last for people exposed to SARS-CoV-2 and why some of these second infections, while rare, are presenting as more severe."

Vaccines work by triggering the body's natural immune response to a certain pathogen, arming it with antibodies to fight off future waves of infection.

But it is not at all clear how long Covid-19 antibodies last.

For some diseases, such as measles, infection confers lifelong immunity. For other pathogens, immunity may be fleeting at best.

The authors said the US patient could have been exposed to a very high dose of the virus the second time around, triggering a more acute reaction.

Alternatively, it may have been a more virulent strain of the virus.

Another hypothesis is a mechanism known as antibody dependent enhancement – that is, when antibodies actually make subsequent infections worse, such as with dengue fever.

The researchers pointed out that reinfection of any kind remains rare, with only a handful of confirmed cases out of tens of millions of Covid-19 infections globally.

However, since many cases are asymptomatic and therefore unlikely to have tested positive initially, it may be impossible to know if a given Covid-19 case is the first or second infection.

In a linked comment to The Lancet paper, Akiko Iwasaka, a professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University, said the findings could impact public health measures.

"As more cases of reinfection surface, the scientific community will have the opportunity to understand better the correlates of protection and how frequently natural infections with SARS-CoV-2 induce that level of immunity," she said.

"This information is key to understanding which vaccines are capable of crossing that threshold to confer individual and herd immunity," added Iwasaka, who was not involved in the study. - AFP

PARIS: Covid-19 patients may experience more severe symptoms the second time they are infected, according to research released on Tuesday confirming it is possible to catch the potentially deadly disease more than once.

A study published in The Lancet Infectious Diseases journal charts the first confirmed case of Covid-19 reinfection in the United States – the country worst hit by the pandemic – and indicates that exposure to the virus may not guarantee future immunity.


The patient, a 25-year-old Nevada man, was infected with two distinct variants of SARS-CoV-2, the virus that causes Covid-19, within a 48-day time frame.

The second infection was more severe than the first, resulting in the patient being hospitalised with oxygen support.

The paper noted four other cases of reinfection confirmed globally, with one patient each in Belgium, the Netherlands, Hong Kong and Ecuador.

Experts said the prospect of reinfection could have a profound impact on how the world battles through the pandemic.

In particular, it could influence the hunt for a vaccine – the current Holy Grail of pharmaceutical research.

"The possibility of reinfections could have significant implications for our understanding of Covid-19 immunity, especially in the absence of an effective vaccine," said Mark Pandori, for the Nevada State Public Health Laboratory and lead study author.

"We need more research to understand how long immunity may last for people exposed to SARS-CoV-2 and why some of these second infections, while rare, are presenting as more severe."

Vaccines work by triggering the body's natural immune response to a certain pathogen, arming it with antibodies to fight off future waves of infection.

But it is not at all clear how long Covid-19 antibodies last.

For some diseases, such as measles, infection confers lifelong immunity. For other pathogens, immunity may be fleeting at best.

The authors said the US patient could have been exposed to a very high dose of the virus the second time around, triggering a more acute reaction.

Alternatively, it may have been a more virulent strain of the virus.

Another hypothesis is a mechanism known as antibody dependent enhancement – that is, when antibodies actually make subsequent infections worse, such as with dengue fever.

The researchers pointed out that reinfection of any kind remains rare, with only a handful of confirmed cases out of tens of millions of Covid-19 infections globally.

However, since many cases are asymptomatic and therefore unlikely to have tested positive initially, it may be impossible to know if a given Covid-19 case is the first or second infection.

In a linked comment to The Lancet paper, Akiko Iwasaka, a professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University, said the findings could impact public health measures.

"As more cases of reinfection surface, the scientific community will have the opportunity to understand better the correlates of protection and how frequently natural infections with SARS-CoV-2 induce that level of immunity," she said.

"This information is key to understanding which vaccines are capable of crossing that threshold to confer individual and herd immunity," added Iwasaka, who was not involved in the study. - AFP

if u think profit enough, just sell,
easy, simple.
people will buy,
for at least this stock will reach rm4 this month.

carepls will follow the top 4

carepls will follow the top 4

2mil volume sell at rm9 cleared,
and people still denied big fund not buying topglove

buy and keep it,
hk listing ia just the the tip of iceberg,
more to come,
good management company,
sure expand their bussiness during top profit.

glove counter consolidation is over,
now is the accumulation phase.

political issue wont affect glove,
i think,
glove counter is the safest trading/investing counter during pandemic

all cmco,
glove still top profit

company top profit,
got dividend,
profit max, got special div.

covid on,
glove on

now tg forum got vaccine expertise as well,
good2

relax,
glove counters,
will follow top 4

scientist will not play2 over vaccine,
will fully test,
if got side effect, people become zombie,
thats the end

it ist set,
gonna fly,
hop on.

people and institution will slowly withdraw their money from other sector, will focus on healthcare.

economic will not recover,
other sector already have bad time during mco,
now try to recover,
but seems will not easy, as long as covid around.

health care will thrive during these times

relax,
daily uptrend intact,
glove stock.
carepls will follow the top 4

volatility favours contra,
that is why they try to push down the price,
collect cheap.

while bad counter, they try to push up,
after already park low, and disposed when cooked enough.

so, for contra,
safe place to play is good stock,
while spreading fear.

volatility favours contra,
that is why they try to push down the price,
collect cheap.

while bad counter, they try to push up,
after already park low, and disposed when cooked enough.

so, for contra,
safe place to play is good stock,
while spreading fear.

covid raging,
demand still high le,
vaccine on,
demand still high le,
it is not that u can vaccine everyone in just 1month,
it take years.

let us see,
will they sell cheap,
becaus of vacc news
while covid still raging

Vaccine is in progress,
we always hope,
but, wont be easy to produce vaccine without side effect,
virus also mutate.

for glove, when red, it is time to collect.
let see how low can we collect,
because of that vaccine news hope.

lol vaccine again,
time to collect

with cvid cases in mys rising,
other counter share price will slowly crash,

investor dont like uncertainty,
people will focus on healthcare counter that profit even during mco,
glove counters will lead,
good management will grab this opportunity to expand their bussiness.